Dr. Tyler Michael Seibert, MD, PhD

Dr. Seibert practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Seibert's NPI, 1679815963, was assigned on March 25, 2013. Dr. Seibert graduated from UC San Diego School of Medicine in 2013. Dr. Seibert holds California license A135004.

Dr. Seibert's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Seibert's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Seibert is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seibert practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Seibert's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Seibert is board certified in radiation oncology by the American Board of Radiology. Dr. Seibert is licensed in California.

Dmand AI lists bladder cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation and prostate cancer radiation among the conditions Dr. Seibert treats.

CMS data shows 956 Medicare services from Dr. Seibert across 13 procedure codes in 2024, for 164 Medicare patients. Medicare paid $77,674 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 164 Medicare patients who saw Dr. Seibert in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have cancer, and 71% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seibert's median patient age at 67, with 43% women.

In 2024, Dr. Seibert wrote 133 Medicare Part D claims for 35 patients. 94% of them were for generic drugs. CMS names the drug for 118 of them, across 3 drugs with 11 or more claims each, at $2,222 in total drug cost. In 2023, CMS named 104 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Seibert for performance year 2024, reported as part of a group. Dr. Seibert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seibert as offering telehealth.

Dmand AI links 102 papers to Dr. Seibert, published from 2010 to 2025. 2024 was the busiest year, with 20. The most frequent topics are Prostatic Neoplasms, Magnetic Resonance Imaging and Brain Neoplasms. Dr. Seibert has published most often in Int J Radiat Oncol Biol Phys. Dr. Seibert's most frequent co-authors are Jona Ashok Hattangadi-Gluth, MD, Nikdokht Farid, MD and Rebecca Rakow-Penner.

Dmand AI links Dr. Seibert to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 65 general payments to Dr. Seibert from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. GE Healthcare paid the most, $8,767.

Dmand AI lists 2 awards for Dr. Seibert, most recently Medical Scientist Training Program in 2013.

Dr. Seibert graduated from UC San Diego School of Medicine in 2013. Dr. Seibert is a member of ASTRO and RSNA.

Dr. Seibert is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.